Diagonal Bio AB (DIABIO) — Defensive Interval Ratio

Latest as of September 2025: 9 days

Diagonal Bio AB (DIABIO) has a Defensive Interval Ratio of 9 days as of September 2025. Defensive assets of Skr53.00K (cash Skr-, short-term investments Skr-, receivables Skr53.00K) cover 9 days of daily cash needs of Skr5.84K/day. See DIABIO net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

9 days
Days of operational coverage

Defensive Assets

Skr53.00K
Cash + ST Investments + Receivables

Daily Cash Need

Skr5.84K
Current Liabilities ÷ 365

Current Liabilities

Skr2.13 Million
SEK

Diagonal Bio AB Defensive Interval Ratio (2020–2024)

This chart shows how Diagonal Bio AB's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 9 days, meaning defensive assets of Skr53.00K can fund 9 days of operations without new revenue. See DIABIO net asset quality index to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Diagonal Bio AB (2020–2024)

The table below presents the year-by-year Defensive Interval Ratio for Diagonal Bio AB from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see DIABIO company net worth.

Year DIR (days) Defensive Assets (SEK) Daily Cash Need Cash ST Investments Change (days)
2024 0 days Skr0.00 Skr6.95K/day Skr- Skr- ▼ -26 days
2023 26 days Skr523.00K Skr19.89K/day Skr- Skr- ▼ -63 days
2022 89 days Skr680.00K Skr7.61K/day Skr- Skr- ▲ +10 days
2021 79 days Skr466.00K Skr5.87K/day Skr- Skr- ▼ -31 days
2020 110 days Skr326.67K Skr2.96K/day Skr- Skr-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)